multiple myeloma - Articles and news items

Treating multiple myeloma: An interview with Janssen

Blog, Z Homepage promo / 17 May 2017 / Dr Catherine Taylor, Haematology Therapeutic Area Lead, Janssen EMEA

We caught up with Janssen’s Dr Catherine Taylor to talk monoclonal antibodies, the rise of immuno-oncology and treating multiple myeloma…

EC extends approval for Janssen’s daratumumab to include multiple myeloma patients

Industry news / 3 May 2017 / Niamh Marriott, Junior Editor

The EC has granted approval to Janssen Daralex (daratumumab) for use in combination, for the treatment of adult patients with multiple myeloma (MM)…

multiple myeloma

NICE does not recommend Janssen’s multiple myeloma drug

Industry news / 29 March 2017 / Niamh Marriott, Junior Editor

NICE) has published new draft guidance not recommending daratumumab monotherapy (Darzalex, Janssen) to treat some people with multiple myeloma…

REVLIMID

Janssen’s monoclonal antibody receives positive CHMP opinion to treat multiple myeloma

Industry news / 28 February 2017 / Niamh Marriott, Digital Editor

If approved by the European Commission, daratumumab can be used for the treatment of adult patients with multiple myeloma…

Genmab to trial daratumumab in combination with carfilzomib to treat multiple myeloma

Industry news / 17 November 2016 / Niamh Louise Marriott, Digital Content Producer

Genmab’s daratumumab (darazalex) will be investigated in a Phase III clinical study in combination with carfilzomib (kyprolis) and dexamethasone…

FDA grants priority review for Genmabs’ daratumumab to treat relapsed multiple myeloma

Industry news / 12 October 2016 / Niamh Louise Marriott, Digital Content Producer

The FDA has assigned a prescription drug user fee act (PDUFA) target date of February 17, 2017 to take a decision on daratumumab in this indication…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+